Ardent Health (NYSE:ARDT) Releases FY 2025 Earnings Guidance

Key Points

• Ardent Health updated its FY 2025 earnings guidance with an EPS range of 1.730-2.01, slightly below the consensus estimate of 1.914, and revenue guidance of $6.2 billion-$6.5 billion, compared to a consensus of $6.3 billion.
• The stock experienced a 3.6% increase in trading, closing at $10.68, with a market cap of $1.53 billion and a price-to-earnings ratio of 6.55.
• Brokerage ratings vary, with one analyst issuing a sell, one a hold, while ten gave buy ratings, and two issued strong buy ratings, leading to a consensus rating of "Moderate Buy" with a target of $20.30.

Ardent Health (NYSE:ARDT - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 1.730-2.01 for the period, compared to the consensus estimate of 1.914. The company issued revenue guidance of $6.2 billion-$6.5 billion, compared to the consensus revenue estimate of $6.3 billion.

Ardent Health Stock Performance

Shares of NYSE ARDT traded up $0.40 during mid-day trading on Friday, hitting $11.87. The stock had a trading volume of 497,421 shares, compared to its average volume of 540,261. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.98 and a current ratio of 2.13. The company has a 50 day moving average of $12.68 and a two-hundred day moving average of $13.47. Ardent Health has a twelve month low of $10.10 and a twelve month high of $20.72. The firm has a market cap of $1.70 billion and a PE ratio of 6.56.

Ardent Health (NYSE:ARDT - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.22. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.54 billion. Research analysts predict that Ardent Health will post 1.23 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently issued reports on ARDT shares. KeyCorp cut their target price on Ardent Health from $24.00 to $20.00 and set an "overweight" rating on the stock in a research report on Thursday. Bank of America lowered shares of Ardent Health from a "neutral" rating to an "underperform" rating and lowered their price target for the company from $15.50 to $14.60 in a report on Wednesday, July 16th. Stephens reaffirmed an "overweight" rating and issued a $21.00 price target on shares of Ardent Health in a report on Tuesday, May 20th. Wall Street Zen raised shares of Ardent Health from a "buy" rating to a "strong-buy" rating in a report on Saturday. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $21.00 price target on shares of Ardent Health in a report on Thursday, May 15th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $19.97.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of ARDT. Goldman Sachs Group Inc. raised its position in shares of Ardent Health by 1,684.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company's stock worth $10,558,000 after purchasing an additional 724,841 shares during the last quarter. Jane Street Group LLC raised its position in shares of Ardent Health by 235.1% during the 1st quarter. Jane Street Group LLC now owns 57,468 shares of the company's stock worth $790,000 after purchasing an additional 40,318 shares during the last quarter. Acadian Asset Management LLC raised its holdings in Ardent Health by 574.9% in the 1st quarter. Acadian Asset Management LLC now owns 40,238 shares of the company's stock valued at $550,000 after acquiring an additional 34,276 shares during the last quarter. Creative Planning acquired a new stake in Ardent Health in the 2nd quarter valued at about $216,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Ardent Health by 103.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company's stock valued at $194,000 after acquiring an additional 7,182 shares during the last quarter.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.